ADVANZ PHARMA Corp.

ADVANZ PHARMA is a global pharmaceutical company determined to deliver sustainable value across our portfolio of products in the global specialty off patent sector.



Contact Information
Adam Peeler 
Tel: 905-842-5150 x 240
[email protected]

Latest

Nov 07, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results

Third quarter 2019 revenue of $120 million Third quarter 2019 net loss of $119 million Third quarter 2019 Adjusted EBITDA1 of $56 million Generated cash flows from operating activities of $151...

Oct 24, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results

TORONTO, Oct. 24, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients and...

Aug 07, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 2019 Adjusted EBITDA1 of $60 million Generated cash flow from operating activities of $97...

Jul 25, 2019, 07:00 ET ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin

MISSISSAUGA, ON, July 25, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

Jul 24, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results

MISSISSAUGA, ON, July 24, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients...

Jun 17, 2019, 18:20 ET ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders

MISSISSAUGA, ON, June 17, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or the "Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

Jun 11, 2019, 08:49 ET ADVANZ PHARMA Corp. Announces Non-Deal Roadshow for European-based Debt Investors

MISSISSAUGA, ON, June 11, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

May 23, 2019, 07:00 ET ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine

MISSISSAUGA, ON, May 23, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare...

May 10, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

First quarter 2019 revenue of $136 million First quarter 2019 net loss of $8 million First quarter 2019 Adjusted EBITDA1 of $65 million Generated cash flow from operations of $46 million in the first ...

Apr 26, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results

MISSISSAUGA, ON, April 26, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients...

Apr 01, 2019, 07:00 ET ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

Company acquires international rights to Salagen® tablets (pilocarpine hydrochloride) (excluding Japan rights) and Panretin® (alitretinoin) gel 0.1% from Eisai Inc. for $30 million in cash plus...

Mar 14, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

2018 revenue of $537 million, fourth quarter 2018 revenue of $118 million 2018 net income of $1.5 billion, which includes a $1.9 billion gain on debt settlement as part of the Company's transaction...

Feb 21, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Release Date for Fourth Quarter and 2018 Results

MISSISSAUGA, ON, Feb. 21, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients...

Jan 30, 2019, 07:30 ET ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections

MISSISSAUGA, ON, Jan. 30, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on helping innovate, shape and grow ...

Nov 29, 2018, 17:00 ET Concordia International Corp. Announces Name Change to ADVANZ PHARMA Corp.

MISSISSAUGA, ON, Nov. 29, 2018 /CNW/ - Concordia International Corp. ("Concordia" or "the Company") (TSX: CXR), today announced that shareholders voted in favour of a special resolution authorizing...

Nov 14, 2018, 07:00 ET Concordia International Corp. Announces Third Quarter 2018 Results

Third quarter 2018 revenue of $128 million Third quarter net income of $1.8 billion, which includes a $1.9 billion gain on debt settlement as part of the Company's recently completed transaction to...

Oct 31, 2018, 17:00 ET Concordia International Corp. Announces Release Date for Third Quarter 2018 Results

MISSISSAUGA, ON, Oct. 31, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in...

Oct 29, 2018, 08:30 ET Concordia International Corp. Adds European Pharmaceutical Industry Expert to its Board of Directors

MISSISSAUGA, ON, Oct. 29, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in...

Oct 15, 2018, 17:00 ET Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors

MISSISSAUGA, ON, Oct. 15, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in...

Oct 09, 2018, 07:00 ET Concordia International Corp. Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization

- ADVANZ PHARMA represents the Company's vision to go beyond expectations to bring sustainable value to customers, healthcare providers, and patients - MISSISSAUGA, ON, Oct. 9, 2018 /CNW/ - Concordia ...

Oct 05, 2018, 16:30 ET Concordia International Corp. Announces Special Meeting of Shareholders To Approve Name Change

MISSISSAUGA, ON, Oct. 5, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in...

Sep 12, 2018, 07:48 ET Concordia International Corp. Provides Further Update On Its Recently Completed Recapitalization Transaction and the Issue Price of its Private Placement

MISSISSAUGA, ON, Sept. 12, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR) issued a further announcement today, at the request of the Investment Industry...

Sep 11, 2018, 13:18 ET Concordia International Corp. Provides Update On Its Recently Completed Recapitalization Transaction

MISSISSAUGA, ON, Sept. 11, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in...

Sep 06, 2018, 21:05 ET Concordia International Corp. Completes Recapitalization Transaction

MISSISSAUGA, ON, Sept. 6, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in...

Aug 13, 2018, 17:20 ET Concordia International Corp. Announces Update on its Recapitalization Transaction, Filing of Certain Documents in connection with the Implementation of its Recapitalization Transaction and Intention

MISSISSAUGA, ON, Aug. 13, 2018 /CNW/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR) announced today that in connection with the previously announced recapitalization...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE